Safety and Efficacy study of ONGLYZA (Saxagliptin) under conditions of actual use - ONGLYZA PMS
Study identifier:NIS-CPH-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
A descriptive study of the efficacy and safety of ONGLYZA (Saxagliptin) under conditions of actual use in the Philippines
Medical condition
Type 2 Diabetes Mellitus
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
542
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Contact
AstraZeneca Philippines Patient Safety Unit Clinical Study Information
Investigators
Principal Investigator
Milagros Tan
AstraZeneca Philippines
